Elisa Scarselli MD

Ms. Elisa Scarselli, MD co-founded Nouscom AG and serves as its Chief Scientific Officer. Ms. Scarselli served as Clinical Director at Okairos AG since 2010. She joined Okairos AG in 2010. Scientist at IRBM / Merck since 1992, she has been working firstly in Hepatitis C infection and immunity and in the last seven years, as group leader, in Oncology.

She is involved in many aspects of Vaccine programs, from the validation of the genetic vaccine platform in pre-clinical models to design of clinical trials and the preparation of dossiers for regulatory agencies. She carried out research at the ZMBH in Heidelberg for two years working in the field of malaria infection. Ms. Scarselli has a degree in Medicine, residency in Hematology and Master in Scientific and regulatory perspectives of drugs development.